Eisai No Longer Distributing Aricept, Aciphex Through Cardinal
This article was originally published in The Pink Sheet Daily
Executive Summary
Brands will still be available through McKesson, AmerisourceBergen and 30 other wholesalers, Eisai says in letter to trade. Is there trouble ahead for fee-for-service distribution model?
You may also be interested in...
Cardinal, Eisai Come To Terms On “Fee-For-Service” Distribution
Companies enter multi-year agreement under which Cardinal will be paid fees for distributing Aricept, Aciphex and Zonegran. Deal is announced one week after Cardinal discontinued purchases of Eisai products – and the day after Pfizer declares it will not pay fees to wholesalers.
Cardinal, Eisai Come To Terms On “Fee-For-Service” Distribution
Companies enter multi-year agreement under which Cardinal will be paid fees for distributing Aricept, Aciphex and Zonegran. Deal is announced one week after Cardinal discontinued purchases of Eisai products – and the day after Pfizer declares it will not pay fees to wholesalers.
Pfizer Says No To "Fee-For-Service" Contracts With Wholesalers
The manufacturer maintains that wholesalers "purchase and resell products for their own account and not as a service to Pfizer." Cardinal will no longer distribute Eisai products, including the Alzheimer's drug Aricept, marketed in partnership with Pfizer.